Yahoo

Moderna fined for ‘luring children into Covid vaccine trials’ with teddy bears

Moderna has been ordered to pay almost £44,000 over the adverts that appeared on X Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with ...
News on 6

What to know about Moderna’s new ‘mNexspike’ COVID-19 vaccine

The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is part of a ...
Healio

FDA approves Moderna’s lower-dose COVID-19 vaccine for some

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The new low-dose vaccine is one-fifth the size of ...
Yahoo

FDA clears Moderna’s new COVID vaccine, but with limits

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. CHICAGO — The Food and Drug Administration has granted ...
CBS News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, ...
Benzinga.com

Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Wednesday affirmed a district court’s finding of noninfringement in favor of Moderna, Inc. (NASDAQ:MRNA) in its ongoing patent battle with ...
FierceBiotech

Moderna scraps congenital virus program after vaccine shows little protective effect in phase 3

Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women from the virus in a large phase 3 trial, the biotech announced in a ...
Bloomberg L.P.

Moderna Vaccine Fails to Stop Virus Tied to Birth Defects

Moderna Inc. said its vaccine to prevent cytomegalovirus, a common cause of birth defects, failed to meet its goal in a late-stage trial, a setback for the company still struggling to move past the ...
TipRanks on MSN

Moderna announces global regulatory submissions for seasonal influenza vaccine

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...
TipRanks on MSN

Moderna announces regulatory submissions for seasonal influenza vaccine

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...